Furthermore, Par-4 has been shown to be inactivated by AKT1 in prostate cancer cells, and a Par-4/AKT1 interaction is widely found in prostate cancer, lung cancer, cervical cancer, as well as in benign prostatic hyperplasia and normal human embryonic lung fibroblasts [19]. Here, AKT1 is linked to prostate carcinoma.